(Reuters) – Moderna Inc’s COVID-19 vaccine showed modest reductions in neutralizing antibodies against emerging variants, including the Delta variant first
Home » covid-19 vaccine »
Booster May Be Needed for J&J Shot as Delta Variant Spreads, Some Experts Already Taking Them
NEW YORK (Reuters) – Infectious disease experts are weighing the need for booster shots of the Pfizer/BioNTech or Moderna mRNA-based
Kremlin Blames Vaccine Hesitancy as Delta Variant Drives Moscow Surge
MOSCOW (Reuters) – The Kremlin on Friday blamed a surge in COVID-19 cases on reluctance to have vaccinations and “nihilism”
US Vaccine Surplus Grows by the Day as Expiration Dates Loom
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. In Tennessee and North Carolina, demand
CVST Risk Still Higher With COVID-19 Than With AZ, J&J Vaccination
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Another study has suggested that rates
German Vaccine Seekers Getting Aggressive, Doctors Say
BERLIN (Reuters) – Germans desperate to be vaccinated against the coronavirus are becoming increasingly aggressive, doctors said on Wednesday, as
One AZ COVID-19 Vaccine Dose Gives 80% Lower Death Risk: English Data
LONDON (Reuters) – Data from the rollout of AstraZeneca’s COVID-19 vaccine shows one dose of the shot is associated with
Key EU Countries Rebuff Biden on Sharing COVID Vaccine Patents
BRUSSELS (Reuters) – European countries distanced themselves on Friday from a proposal backed by U.S. President Joe Biden to waive
AstraZeneca’s Soriot Defends COVID Vaccine Supply
LONDON (Reuters) – Pascal Soriot, who is under intense fire from the European Union over the delivery of AstraZeneca’s COVID-19
Novartis Could Boost CureVac Vaccine Production, if Needed: CEO
ZURICH (Reuters) – Novartis is scaling up facilities to make COVID-19 vaccine doses for German drugmaker CureVac and could boost